The Abraaj Growth Markets Health Fund (AGHF) is in the process of separating from the Abraaj Group to ensure continuity and build a stable platform for the future.
AlixPartners has announced that it has been appointed by investors of the Abraaj AGHF to manage the fund's separation from Abraaj Group to ensure its continuity in delivering accessible, affordable as well as quality healthcare in developing countries.
The AGHF provides affordable, quality healthcare to under-served low and middle-income patients throughout Sub-Saharan Africa and South Asia, with performance measured by both financial returns and development impact metrics.
AlixPartners said it is working alongside the fund’s senior operational team and the provisional liquidators of Abraaj Investment Management Limited (AIML) in search for a permanent replacement investment manager to manage the fund and oversee its vital work.
The AGHF owns 26 hospitals, 17 clinics as well as 32 diagnostics centres in India, Pakistan and Kenya, the fund is in the process of entering the Nigerian market.
The key investors in the $1 billion investment fund are the Bill & Melinda Gates Foundation, CDC Group as well as International Finance Corporation, Medtronic and Proparco, reported local daily, TradeArabia.